SecBot SecBot
SECBOTREPLAY Home › Report › AGL

AGL · Q3 revenue +6% YoY, guidance up

agilon health, inc. · 8-K filed Nov 4, 2026 at 16:07 ET

At the news

BULLISHIMPACT 7/10

8-K filed Nov 4, 2026 at 16:07 ET

agilon health reported Q3 2026 revenue of $1.52B (+6% YoY) and net income of $35M vs a net loss of $110M a year ago, driven by improved medical services expense ratio (88.5% vs 104.0%). The company raised full-year 2026 Adjusted EBITDA guidance to $145M-$155M from $75M-$95M, reflecting strong operational execution and favorable claims development.

  • Q3 2026 total revenue $1.52B, +6% YoY from $1.44B
  • Net income $35M vs net loss of $110M in Q3 2025
  • Adjusted EBITDA $64M vs negative $91M in Q3 2025
  • Medical services expense ratio improved to 88.5% from 104.0%

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access